The FDA approved Pentax’s ED34-i10T, a duodenoscope with a disposable, single-use distal cap.
Allergan’s board of directors authorized the company to buy back $2 billion in stock, while also committing to increasing its quarterly dividends and reaffirming its decision to pay down $3.75 billion in debt by 2018.
The FDA approved Bracco Diagnostics’ Tagitol V oral suspension for adult patients undergoing virtual colonoscopy.
A study from England-based Oxford University further validated Medial EarlySign’s ColonFlag.
Landos Biopharma completed a series A financing round raising $10 million.
More articles on gastroenterology:
Landos Biopharma raises $10M in series A funding round — 3 insights
GI leader to know: Dr. Nicole Griglione of GI Associates
Stock market week-in-review for 5 large GI companies — Sept. 18-22
